HomeCompareZBH vs NDAQ

ZBH vs NDAQ: Dividend Comparison 2026

ZBH yields 1.08% · NDAQ yields 1.29%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NDAQ wins by $120.1K in total portfolio value
10 years
ZBH
ZBH
● Live price
1.08%
Share price
$88.62
Annual div
$0.96
5Y div CAGR
0.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.2K
Annual income
$118.64
Full ZBH calculator →
NDAQ
NDAQ
● Live price
1.29%
Share price
$83.52
Annual div
$1.08
5Y div CAGR
62.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.3K
Annual income
$64,247.81
Full NDAQ calculator →

Portfolio growth — ZBH vs NDAQ

📍 NDAQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZBHNDAQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZBH + NDAQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZBH pays
NDAQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZBH
Annual income on $10K today (after 15% tax)
$92.08/yr
After 10yr DRIP, annual income (after tax)
$100.84/yr
NDAQ
Annual income on $10K today (after 15% tax)
$109.91/yr
After 10yr DRIP, annual income (after tax)
$54,610.64/yr
At 15% tax rate, NDAQ beats the other by $54,509.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZBH + NDAQ for your $10,000?

ZBH: 50%NDAQ: 50%
100% NDAQ50/50100% ZBH
Portfolio after 10yr
$81.3K
Annual income
$32,183.22/yr
Blended yield
39.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NDAQ right now

ZBH
Analyst Ratings
17
Buy
21
Hold
3
Sell
Consensus: Hold
Price Target
$105.60
+19.2% upside vs current
Range: $89.00 — $122.00
Altman Z
1.7
Piotroski
7/9
NDAQ
Analyst Ratings
23
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$113.60
+36.0% upside vs current
Range: $108.00 — $120.00
Altman Z
2.5
Piotroski
9/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZBH buys
17
NDAQ buys
10
PoliticianChamberTickerTypeAmountDate
April Delaney🏢 House$NDAQ▲ Buy$1,001 - $15,0002026-02-27
Ro Khanna🏢 House$NDAQ▼ Sell$1,001 - $15,0002025-10-27
Ro Khanna🏢 House$NDAQ▼ Sell$1,001 - $15,0002025-10-27
Ro Khanna🏢 House$NDAQ▼ Sell$1,001 - $15,0002025-10-23
Ro Khanna🏢 House$NDAQ▼ Sell$1,001 - $15,0002025-10-23
April Delaney🏢 House$NDAQ▲ Buy$15,001 - $50,0002025-10-22
April Delaney🏢 House$NDAQ▲ Buy$1,001 - $15,0002025-10-09
Ro Khanna🏢 House$NDAQ▼ Sell$1,001 - $15,0002025-09-26
April Delaney🏢 House$NDAQ▲ Buy$15,001 - $50,0002025-09-19
Ro Khanna🏢 House$NDAQ▼ Sell$1,001 - $15,0002025-09-08
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZBHNDAQ
Forward yield1.08%1.29%
Annual dividend / share$0.96$1.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0.2%62.3%
Portfolio after 10y$21.2K$141.3K
Annual income after 10y$118.64$64,247.81
Total dividends collected$1.1K$114.0K
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusHoldBuy
Analyst price target$105.60$113.60

Year-by-year: ZBH vs NDAQ ($10,000, DRIP)

YearZBH PortfolioZBH Income/yrNDAQ PortfolioNDAQ Income/yrGap
1← crossover$10,809$108.54$10,910$209.87$101.00NDAQ
2$11,675$109.86$12,021$347.30$346.00NDAQ
3$12,603$111.13$13,443$580.44$840.00NDAQ
4$13,598$112.34$15,368$984.57$1.8KNDAQ
5$14,663$113.51$18,151$1,707.33$3.5KNDAQ
6$15,804$114.62$22,481$3,058.70$6.7KNDAQ
7$17,026$115.69$29,800$5,746.07$12.8KNDAQ
8$18,335$116.71$43,440$11,553.61$25.1KNDAQ
9$19,736$117.70$72,027$25,545.86$52.3KNDAQ
10$21,236$118.64$141,316$64,247.81$120.1KNDAQ

ZBH vs NDAQ: Complete Analysis 2026

ZBHHealthcare

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Full ZBH Calculator →

NDAQFinancials

Nasdaq, Inc. operates as a technology company that serves capital markets and other industries worldwide. The Market Technology segment includes anti financial crime technology business, which offers Nasdaq Trade Surveillance, a SaaS solution for brokers and other market participants to assist them in complying with market rules, regulations, and internal market surveillance policies; Nasdaq Automated Investigator, a cloud-deployed anti-money laundering tool; and Verafin, a SaaS technology provider of anti-financial crime management solutions. This segment also handles assets, such as cash equities, equity derivatives, currencies, interest-bearing securities, commodities, energy products, and digital currencies. The Investment Intelligence segment sells and distributes historical and real-time market data; develops and licenses Nasdaq-branded indexes and financial products; and provides investment insights and workflow solutions. The Corporate Platforms segment operates listing platforms; and offers investor relations intelligence and governance solutions. As of December 31, 2021, it had 4,178 companies listed securities on The Nasdaq Stock Market, including 1,632 listings on The Nasdaq Global Select Market; 1,169 on The Nasdaq Global Market; and 1,377 on The Nasdaq Capital Market. The Market Services segment includes equity derivative trading and clearing, cash equity trading, fixed income and commodities trading and clearing, and trade management service businesses. This segment operates various exchanges and other marketplace facilities across various asset classes, which include derivatives, commodities, cash equity, debt, structured products, and exchange traded products; and provides broker, clearing, settlement, and central depository services. The company was formerly known as The NASDAQ OMX Group, Inc. and changed its name to Nasdaq, Inc. in September 2015. Nasdaq, Inc. was founded in 1971 and is headquartered in New York, New York.

Full NDAQ Calculator →
📬

Get this ZBH vs NDAQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZBH vs SCHDZBH vs JEPIZBH vs OZBH vs KOZBH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.